Publications by authors named "F Pavlotsky"
Pemphigus vulgaris is a chronic autoimmune blistering disease with significant morbidity. Rituximab, approved as its first-line treatment, effectively induces remission. However, few studies have analysed the prognostic factors for improved rituximab outcomes.
View Article and Find Full Text PDFObjectives: Early initiation of biologic therapies for psoriasis has been explored to prevent or delay the onset of psoriatic arthritis (PsA). This has renewed interest in the potential role of methotrexate (MTX) in mitigating PsA risk in newly diagnosed psoriasis patients. The aim of this study was to evaluate the impact of early MTX initiation on PsA incidence in individuals with psoriasis.
View Article and Find Full Text PDFArticle Synopsis
- The study examines the link between Parkinson's disease (PD) and skin cancer risk factors, looking specifically at actinic keratosis (AK), non-melanoma skin cancer (NMSC), and cutaneous malignant melanoma (CMM) among individuals with and without PD.
- A total of 141 patients with PD and 155 controls were analyzed, revealing that CMM was more prevalent in PD patients, with risk factors like prolonged sun exposure, freckles, and solar lentigines particularly associated with skin tumours in the PD group.
- The research indicates that while certain skin tumour risk factors exist, PD status by itself isn't independently linked to these risks, highlighting the need for regular dermatological
Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members.
Int J Radiat Oncol Biol Phys
November 2024
Purpose: We aim to determine the current treatment patterns and recommendations among physicians for cutaneous lymphomas and to identify the types of skin lymphomas for which existing radiation regimens need improvement.
Methods And Materials: A questionnaire from the European Organisation for Research and Treatment of Cancer was distributed to all members of the Cutaneous Lymphoma Tumour Group and Radiation Oncology Scientific Council. This online survey included 13 questions regarding treatment practices for patients with cutaneous lymphoma.